| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Epidemiological Model to Estimate the Prevalence of Diffuse Large B-Cell Lymphoma in the United States
|
Chihara, Dai
|
|
|
22 |
12 |
p. e1092-e1099
|
artikel
|
| 2 |
Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma
|
Atieh, Tahani
|
|
|
22 |
12 |
p. 912-919
|
artikel
|
| 3 |
Characteristics and Outcomes of Alberta Lymphoma Patients with a History of Immunosuppressive therapy for Autoimmune Conditions
|
Kantharia, Kosha
|
|
|
22 |
12 |
p. 894-902
|
artikel
|
| 4 |
Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group
|
Chanswangphuwana, Chantiya
|
|
|
22 |
12 |
p. e1075-e1083
|
artikel
|
| 5 |
Dupilumab in Multiple Myeloma: A Case Series
|
Owji, Shayan
|
|
|
22 |
12 |
p. 928-932
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
22 |
12 |
p. A1-A2
|
artikel
|
| 7 |
Impact of Fluoroquinolone Prophylaxis on Neutropenic Fever, Infections, and Antimicrobial Resistance in Newly Diagnosed AML Patients
|
Caro, Jessica
|
|
|
22 |
12 |
p. 903-911
|
artikel
|
| 8 |
Ixazomib With or Without Rituximab Following Maintenance Autologous Stem Cell Transplant in Mantle Cell Lymphoma: A Single-Center Phase I Trial
|
Romancik, Jason T.
|
|
|
22 |
12 |
p. e1084-e1091
|
artikel
|
| 9 |
Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma
|
Yusuf, Abdel Rahem S.
|
|
|
22 |
12 |
p. 920-927
|
artikel
|
| 10 |
Oral Antineoplastics in Acute Myeloid Leukemia: A Comprehensive Review
|
Gandhi, Arpita
|
|
|
22 |
12 |
p. e1033-e1049
|
artikel
|
| 11 |
Response to “A Review and Update with Perspective of Evidence that the Herbicide Glyphosate (Roundup) is a Cause of Non-Hodgkin Lymphoma”
|
Tarone, Robert E.
|
|
|
22 |
12 |
p. e1050
|
artikel
|
| 12 |
SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome
|
Falantes, Jose F.
|
|
|
22 |
12 |
p. e1059-e1066
|
artikel
|
| 13 |
SOHO State of the Art and Next Questions: Treatment of Higher-Risk Myelodysplastic Syndromes
|
Aubrey, Brandon J.
|
|
|
22 |
12 |
p. 869-877
|
artikel
|
| 14 |
SOHO State of the Art Updates and Next Questions: Measurable Residual Disease in Acute Lymphoblastic Leukemia - Optimization and Innovation in 2022 and Beyond
|
Dekker, Simone E.
|
|
|
22 |
12 |
p. 878-882
|
artikel
|
| 15 |
Table of Contents
|
|
|
|
22 |
12 |
p. A3-A5
|
artikel
|
| 16 |
The Prognostic Significance of CD79B Mutation in Diffuse Large B-Cell Lymphoma: A Meta-analysis and Systematic Literature Review
|
Xu, Peng-Peng
|
|
|
22 |
12 |
p. e1051-e1058.e1
|
artikel
|
| 17 |
Thrombocytopenia in Patients With Myelofibrosis: A Practical Management Guide
|
Tremblay, Douglas
|
|
|
22 |
12 |
p. e1067-e1074
|
artikel
|
| 18 |
Treatment of Ph-Negative Acute Lymphoblastic Leukemia in Adolescents and Young Adults with an Affordable Outpatient Pediatric Regimen
|
Gómez-De León, Andrés
|
|
|
22 |
12 |
p. 883-893
|
artikel
|
Tijdschrift beschrijving